Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M20,949Revenue $M644Net Margin (%)2.1Altman Z-Score13.8
Enterprise Value $M20,981EPS $0.1Operating Margin %4.7Piotroski F-Score5
P/E(ttm)2,190Beneish M-Score-1.9Pre-tax Margin (%)2.1Higher ROA y-yY
Price/Book37410-y EBITDA Growth Rate %--Quick Ratio3.8Cash flow > EarningsY
Price/Sales31.05-y EBITDA Growth Rate %--Current Ratio3.8Lower Leverage y-yY
Price/Free Cash Flow352y-y EBITDA Growth Rate %--ROA % (ttm)1.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M179ROIC % (ttm)68.9Gross Margin Increase y-yN

Gurus Latest Trades with INCY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INCYVanguard Health Care Fund 2015-06-30 Reduce-0.15%$88.46 - $110.15
($103.32)
$ 116.0712%Reduce 7.50%9,411,543
INCYJoel Greenblatt 2015-06-30 Buy 0.01%$88.46 - $110.15
($103.32)
$ 116.0712%New holding10,363
INCYKen Fisher 2015-06-30 Reduce$88.46 - $110.15
($103.32)
$ 116.0712%Reduce 7.90%13,695
INCYMariko Gordon 2014-12-31 Sold Out -0.05%$45.6 - $78.89
($65.73)
$ 116.0777%Sold Out0
INCYKen Fisher 2014-12-31 Add$45.6 - $78.89
($65.29)
$ 116.0778%Add 97.08%14,870
INCYVanguard Health Care Fund 2014-09-30 Add0.07%$45.35 - $56.59
($50.13)
$ 116.07132%Add 6.08%10,174,343
INCYMariko Gordon 2014-09-30 Add$45.35 - $56.59
($50.13)
$ 116.07132%Add 6.55%25,283
INCYKen Fisher 2014-09-30 Reduce$45.35 - $55.78
($50.07)
$ 116.07132%Reduce 38.28%7,545
INCYVanguard Health Care Fund 2014-06-30 Add0.68%$43.1 - $56.39
($50.98)
$ 116.07128%Add 95.66%9,591,143
INCYMariko Gordon 2014-06-30 Reduce-0.19%$43.1 - $56.39
($50.98)
$ 116.07128%Reduce 78.93%23,728
INCYGeorge Soros 2014-06-30 Sold Out -0.01%$43.1 - $56.39
($50.98)
$ 116.07128%Sold Out0
INCYKen Fisher 2014-06-30 Buy $43.1 - $56.39
($50.98)
$ 116.07128%New holding12,225
INCYVanguard Health Care Fund 2014-03-31 Add0.07%$49.94 - $68.83
($62.06)
$ 116.0787%Add 9.97%4,901,968
INCYMariko Gordon 2014-03-31 Reduce-0.03%$49.94 - $68.83
($62.06)
$ 116.0787%Reduce 12.67%112,623
INCYGeorge Soros 2014-03-31 Buy 0.01%$49.94 - $68.83
($61.83)
$ 116.0788%New holding23,200
INCYVanguard Health Care Fund 2013-12-31 Add0.1%$34.71 - $51.34
($43.56)
$ 116.07166%Add 17.08%4,457,643
INCYMariko Gordon 2013-12-31 Reduce-0.06%$34.71 - $51.34
($43.45)
$ 116.07167%Reduce 20.50%128,959
INCYVanguard Health Care Fund 2013-06-30 Add0.05%$19.07 - $24.49
($21.85)
$ 116.07431%Add 21.52%3,807,443
INCYVanguard Health Care Fund 2013-03-31 Buy 0.29%$16.61 - $24.95
($20.44)
$ 116.07468%New holding3,133,100
INCYGeorge Soros 2011-03-31 Sold Out $13.37 - $16.56
($14.71)
$ 116.07689%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INCY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


INCY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Siegel Eric H.EVP, General Counsel 2015-08-13Sell2,222$107.697.78view
Levy Richard SEVP, Chief Drug Dev Officer 2015-08-06Sell3,936$111.953.68view
Wenqing YaoEVP, Discovery Medicinal and P 2015-07-15Sell12,850$116.7-0.54view
Levy Richard SEVP, Chief Drug Dev Officer 2015-07-15Sell70,217$120-3.28view
Siegel Eric H.EVP, General Counsel 2015-07-14Sell2,222$113.612.17view
Levy Richard SEVP, Chief Drug Dev Officer 2015-07-06Sell3,937$1078.48view
Daly James MEVP, Chief Commercial Officer 2015-06-23Sell11,691$108.247.23view
Levy Richard SEVP, Chief Drug Dev Officer 2015-06-19Sell20,000$108.137.34view
Siegel Eric H.EVP, General Counsel 2015-06-12Sell2,223$105.3110.22view
Levy Richard SEVP, Chief Drug Dev Officer 2015-06-08Sell3,937$107.587.89view

Quarterly/Annual Reports about INCY:

    News about INCY:

    Articles On GuruFocus.com
    Weekly CFO Sells Highlight: Aramark, Incyte Corp Ltd., Facebook Inc. Jun 09 2014 
    Weekly Insider Sells Highlight: ARMK, INCY, ESC, HUN Jun 08 2014 
    Weekly Insider Sells Highlight: CPN, INCY, GPK, CODE Feb 23 2014 
    Weekly CFO Sells Highlight: Pandora Media Inc, Incyte Corp Ltd, Google Inc, American Airlines Group Feb 24 2014 
    Weekly CEO Sells Highlight: ExOne Co, Atmel Corporation, Best Buy and Incyte Corp Ltd. Sep 22 2013 
    Weekly CFO Sells Highlight: INTU, INCY, RLD, MIDD, XONE Sep 15 2013 
    Weekly CEO Sells Highlight: DIS, LMT, INCY, ADBE May 14 2012 
    Weekly Top Insider Buys: VTR, INCY, FULT, HMA, CMC Jan 23 2012 
    04 stocks with insider buying of more than $1.5 million since beginning of 2012 Jan 22 2012 
    Weekly CFO Sales Highlight: EPIQ, INCY, AVB, JOSB, PCS, FLO Jun 12 2011 

    More From Other Websites
    Incyte & Hengrui to Develop Anti-PD-1 Monoclonal Antibody Sep 03 2015
    Virtusa, Incyte Score New Highs In Solid Up Session Sep 02 2015
    Analyzing Incyte: What Kind of Company Is It? Sep 02 2015
    INCYTE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Sep 02 2015
    5:35 am Incyte signs GLA with Jiangsu Hengrui Medicine for SHR-1210; Incyte to pay Hengrui $25... Sep 02 2015
    Incyte Announces Global License Agreement with Jiangsu Hengrui Medicine for SHR-1210, an... Sep 02 2015
    Incyte Announces Global License Agreement with Jiangsu Hengrui Medicine for SHR-1210, an... Sep 02 2015
    Incyte Was a Star Performer from August 10–17, 2015 Sep 01 2015
    Incyte to Present at Upcoming Investor Conferences Sep 01 2015
    Incyte to Present at Upcoming Investor Conferences Sep 01 2015
    Incyte, Signet, Sportsman's Flirt With Breakouts Aug 31 2015
    3 Under-The-Radar Biotech Stocks With Bullish Charts Aug 31 2015
    XBI Remains Flat as of August 17, 2015 Aug 31 2015
    INCYTE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Aug 25 2015
    Top 10 Funds & Stocks at Risk of Being Squeezed in Market Turmoil Aug 25 2015
    Incyte Named 7th Most Innovative Company in the World by Forbes Magazine Aug 21 2015
    Incyte Named 7th Most Innovative Company in the World by Forbes Magazine Aug 21 2015
    Coverage initiated on Incyte by Barclays Aug 13 2015
    INCYTE CORP Financials Aug 11 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK